About iCardio.ai
iCardio.ai is a Los Angeles-based healthcare AI company specializing in machine learning and deep learning algorithms for the analysis of ultrasound applications, with a primary focus on echocardiography (heart ultrasounds). The company aims to revolutionize heart disease detection and treatment by providing accessible, accurate, and automated interpretation of cardiac imaging. They have developed an AI system, trained on a proprietary dataset of over 200 million images, to automatically interpret echocardiograms.
iCardio.ai’s flagship product, EchoMeasure™, received U.S. Food and Drug Administration (FDA) 510(k) clearance in October 2024. This software provides an automated, comprehensive imaging workflow and preliminary reporting tool for echocardiographic interpretation, including view classification, quality checks, and automated measurements of cardiac anatomical structures and quantities. Additionally, their AI-based aortic stenosis detection tool, CardioVision™, received FDA Breakthrough Device Designation in February 2024, addressing unmet needs in cardiac diagnostics. The company is also working on EchoGPT, an AI-powered tool capable of autonomously generating complete echocardiography reports.
iCardio.ai has established significant partnerships with major ultrasound vendors and healthcare organizations, including GE Healthcare, Butterfly Network, UltraLinQ, Viz.ai, and Abbott. These collaborations aim to integrate iCardio.ai’s technology into existing ultrasound platforms and PACS systems, broadening the accessibility and utility of echocardiography AI for clinicians globally.
Focus Areas
Business Intelligence
| Technology | Machine learning and deep learning algorithms for ultrasound interpretation, cloud-native or on-premise server deployment, API for integration |
What Physicians Need to Know
iCardio.ai's solutions are designed to enhance diagnostic accuracy and efficiency in echocardiography, potentially leading to earlier diagnosis and improved patient outcomes, especially for conditions like aortic stenosis. [2, 5, 12] The automated measurements and preliminary reports can significantly reduce the time spent on repetitive tasks, addressing issues like Work-Related Musculoskeletal Disorders (WRMSDs) among sonographers. [4] The AI tools also provide objective image quality assessment, which can help maintain IAC accreditation and ensure high-quality ultrasound images. [1] Their technology is being integrated into various ultrasound platforms and PACS systems, aiming for seamless integration into existing clinical workflows. [1, 3, 11] The ability to detect structural heart disease and aortic stenosis from a single ultrasound clip, even in point-of-care settings, can empower non-specialists and facilitate timely referrals. [1, 5, 12]
iCardio.ai offers a simple and straightforward API for easy integration of their AI algorithms into enterprise PACS workflows and hardware. [1, 9] They are actively partnering with ultrasound companies, PACS vendors, and healthcare systems to deliver their technology directly to clinicians. [1, 2, 3, 9, 11, 13]
What the Web Says
iCardio.ai is a company that develops AI-powered software for automating the interpretation of echocardiograms, aiming to improve diagnostic accuracy and efficiency in cardiology. Their products, such as EchoMeasure™ and CardioVision™, have received FDA clearance and Breakthrough Device Designation, respectively. The company leverages a large dataset of echocardiographic images and collaborates with world-leading cardiologists and AI scientists. While there are no direct user reviews on major platforms like G2, Glassdoor, or Capterra specifically for iCardio.ai's products or as an employer, discussions on Reddit and information from other sources highlight the potential benefits and challenges of AI in echocardiography.
Overall: MixedStrengths
- Automates echocardiography measurements and analysis, reducing manual effort and time for clinicians.
- Aims to improve accuracy and consistency by reducing human error and inter-observer variability.
- Integrates into existing cardiac imaging and reporting workflows, streamlining the process.
- FDA-cleared AI tools for automating echocardiography measurements and detecting aortic stenosis.
- Partnerships with major healthcare organizations like GE Healthcare, UltraLinQ, and SARC MedIQ.
- Leverages a proprietary database of over 200 million ultrasound images for robust AI development.
Limitations
- Lack of direct user reviews on major platforms like G2, Glassdoor, and Capterra makes it difficult to assess real-world user satisfaction and employer sentiment.
- General concerns about AI in medicine, such as accuracy, training, trust in technology, and the potential impact on the role of healthcare professionals.
- Potential for AI to be confidently incorrect in interpretations, as seen in some AI ECG tools.
- Challenges in integrating AI tools into existing workflows and addressing potential issues like accuracy and training.
Based on reviews from: Reddit, iCardio.ai official website, Product Hunt, SaaSHub, SoftwareSuggest, G2, RadAISlice, MedAxiom
Last updated: 2026-10-19
Videos
News, demos, and interviews about iCardio.ai.
Videos load interactively. If none appear, search YouTube for iCardio.ai →
Press & Coverage
Frequently Asked Questions
Related Companies
A2z Radiology AI is a Boston-based medical imaging AI company that develops software for comprehensive CT interpretation, initially focusing on abdomen-pelvis CT scans. The company’s primary goal is to enhance diagnostic accuracy and efficiency in medical imaging for healthcare providers by leveraging artificial intelligence. Their flagship product, a2z-Unified-Triage, is FDA-cleared radiological computer-aided triage and notification […]
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Qure.ai is a leading healthcare AI company that leverages deep learning and artificial intelligence to revolutionize medical imaging diagnostics and make healthcare more accessible and affordable globally. The company develops AI-powered solutions for interpreting X-rays and CT scans, addressing critical health needs in areas such as lung, musculoskeletal, cardiovascular, and neurocritical health. Their technology assists […]
Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]
CortiCare is a healthcare AI company specializing in neuro telemetry and remote patient monitoring, primarily focusing on electroencephalogram (EEG) services. The company provides telehealth services and an EEG brain monitoring platform to neurology and critical care areas within hospitals, including ICUs, NICUs, PICUs, and EMUs. Their services aim to enhance the neurological assessment of adult, […]